📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations. (2024)

First Author: Serwanga J

Attributed to: Vaccinology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2024.1348905

PubMed Identifier: 38357547

Publication URI: http://europepmc.org/abstract/MED/38357547

Type: Journal Article/Review

Volume: 15

Parent Publication: Frontiers in immunology

ISSN: 1664-3224